PIC Therapeutics is a biotechnology company focused on fundamentally changing how we treat cancer by developing a new generation of therapeutics based on the modulation of RNA translation.
PIC Therapeutics was founded on the seminal work of Dr. Gerhard Wagner, a professor at Harvard Medical School world-renowned for his scientific expertise in protein structure and his research on interactions of eukaryotic translation initiation factors (eIFs).
PIC Therapeutics, led by President and CEO Dr. Kathy Bowdish, was launched to translate these discoveries into small molecule precision therapeutics to benefit cancer patients.
Our precision-based therapeutics target the “master switch” of cancer signaling pathways, selectively blocking oncogene protein production by modulating the Pre-Initiation Complex (PIC) that drives their mRNA translation. Our selective approach has the potential to simultaneously modulate multiple oncogenic drivers leading to a powerful new generation of cancer-treating therapeutics.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 22 Strathmore Rd,
- in****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- pictherapeutics.com
- Keywords
- cancer research, cancer treatment, oncogene protein, mRNA, eIFs, small molecule precision therapeutics.
- HQ
- Natick, Massachusetts
Pic Therapeutics Questions
Pic Therapeutics's website is pictherapeutics.com
Pic Therapeutics's LinkedIn profile is https://www.linkedin.com/company/pic-therapeutics
Pic Therapeutics has
6 employees.
View email and phone details for 6
employees at Pic Therapeutics.
Pic Therapeutics's industry is
Biotechnology Research
Pic Therapeutics's top competitors are
Triana Biomedicines,
Minervax Aps,
Convergent Therapeutics, Inc.,
Artax Biopharma Inc,
Transcode Therapeutics, Inc.,
Forma Therapeutics,
Cullinan Therapeutics,
Acer Therapeutics Inc.,
Compass Therapeutics Inc.,
Acrivon Therapeutics, Inc..
Pic Therapeutics's support email address is info@pictherapeutics.com
Pic Therapeutics's categories are Biotechnology Research
Pic Therapeutics's founding year is 2016
